Clinical Trials Directory

Trials / Completed

CompletedNCT01688245

A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
765 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Not accepted

Summary

Investigators aim to test the effectiveness of a text-message-based behaivoral intervention in reducing binge drinking among young adults.

Detailed description

Alcohol consumption, especially in the form of heavy episodic drinking (bingeing), is common among young adults. Despite high rates of illness and injury associated with heavy episodic drinking, many young adults are not aware of the risks, few seek help for their drinking and many at-risk are not exposed to prevention-based intervention. Opportunistic screening in hospital Emergency Departments (EDs) tied to behavioral interventions has the potential to prevent future alcohol-related harm among young adults, but efficacy across outcomes has been mixed and large-scale implementation of prevention programs is low. Given the rapidly growing use of cell phone text-messaging (SMS) as a primary form of communication among young adults, SMS could be used to deliver health prevention interventions. We will recruit young adults identified in the ED with hazardous drinking behavior in a 3-arm randomized controlled trial to test the hypothesis that exposure to a 12-week SMS program will result in immediate (3-month) and lasting (6-, and 9-month) decreases in alcohol consumption.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS Assessments & FeedbackWeekly pre-weekend drinking plan and post-weekend drinking outcome assessments with personlaized feedback
BEHAVIORALSMS AssessmentsWeekly post-weekend drinking outcome assessments

Timeline

Start date
2012-11-01
Primary completion
2014-11-01
Completion
2015-05-01
First posted
2012-09-19
Last updated
2015-05-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01688245. Inclusion in this directory is not an endorsement.